Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Jake Liang

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
Gastroenterology|December 30, 2018
Viral Hepatitis and Hepatocellular CarcinomaT Jake Liang, Norah Terrault
Journal of Hepatology|August 16, 2023
Development of a highly potent anti-HBs monoclonal antibody for HBV and HDV therapy: An improvement with unsettled questionsKarim Mouzannar, T Jake Liang
Antiviral Therapy|February 21, 2008
Treatment of chronic hepatitis BRohit Loomba, T Jake Liang
Gastroenterology|June 17, 2020
Coronavirus Disease-19 Has Come Home to Roost in GastroenterologyChristopher Koh, T Jake Liang
Gastroenterology|September 24, 2018
Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus InfectionYuchen Xia, T Jake Liang
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Alternative interferons and immunomodulators in the treatment of hepatitis CHawwa Alao, T Jake Liang
Nature Reviews. Gastroenterology & Hepatology|April 15, 2016
Experimental models of hepatitis B and C - new insights and progressEmmanuel Thomas, T Jake Liang
Antiviral Research|January 29, 2014
What is the future of ribavirin therapy for hepatitis C?Christopher Koh, T Jake Liang
Annals of Internal Medicine|February 22, 2012
Hepatitis C: the end of the beginning and possibly the beginning of the endHarvey J Alter, T Jake Liang
The New England Journal of Medicine|May 17, 2013
Current and future therapies for hepatitis C virus infectionT Jake Liang, Marc G Ghany
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
Gastroenterology|December 30, 2018
Viral Hepatitis and Hepatocellular CarcinomaT Jake Liang, Norah Terrault
Journal of Hepatology|August 16, 2023
Development of a highly potent anti-HBs monoclonal antibody for HBV and HDV therapy: An improvement with unsettled questionsKarim Mouzannar, T Jake Liang
Antiviral Therapy|February 21, 2008
Treatment of chronic hepatitis BRohit Loomba, T Jake Liang
Gastroenterology|June 17, 2020
Coronavirus Disease-19 Has Come Home to Roost in GastroenterologyChristopher Koh, T Jake Liang
Gastroenterology|September 24, 2018
Development of Direct-acting Antiviral and Host-targeting Agents for Treatment of Hepatitis B Virus InfectionYuchen Xia, T Jake Liang
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Alternative interferons and immunomodulators in the treatment of hepatitis CHawwa Alao, T Jake Liang
Nature Reviews. Gastroenterology & Hepatology|April 15, 2016
Experimental models of hepatitis B and C - new insights and progressEmmanuel Thomas, T Jake Liang
Antiviral Research|January 29, 2014
What is the future of ribavirin therapy for hepatitis C?Christopher Koh, T Jake Liang
Annals of Internal Medicine|February 22, 2012
Hepatitis C: the end of the beginning and possibly the beginning of the endHarvey J Alter, T Jake Liang
The New England Journal of Medicine|May 17, 2013
Current and future therapies for hepatitis C virus infectionT Jake Liang, Marc G Ghany
Pageof 22